NCT04051476

Brief Summary

A study to explore whether different dosages of ginger flour in footbaths cause different effects on warmth development as well as on general well-being and the autonomic nervous system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 7, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 9, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

September 16, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

April 28, 2020

Status Verified

April 1, 2020

Enrollment Period

5 months

First QC Date

August 7, 2019

Last Update Submit

April 27, 2020

Conditions

Keywords

Ginger flour footbathsDose-response relationshipThermogenesisInfrared thermographyHeart rate variabilityHealthy volunteers

Outcome Measures

Primary Outcomes (1)

  • 2-item warmth perception measure at the feet after the footbath

    Self-reported warmth perception at both feet, assessed with the "Herdecke warmth perception questionnaire" immediately after the footbath (t2). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4.

    Immediately after the footbath, timepoint 2 (t2)

Secondary Outcomes (23)

  • 2-item warmth perception measure at the feet at t1 and t3

    Immediately before (t1) and 10 minutes following the footbath (t3)

  • 2-item warmth perception measure at the hands at t1, t2 and t3

    Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3).

  • 2-item warmth perception measure at the head at t1, t2 and t3

    Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  • 1-item overall warmth perception measure at t1, t2 and t3

    Immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3)

  • Warmth perception and skin stimulus at the feet during the footbath

    Up to 20 minutes

  • +18 more secondary outcomes

Study Arms (4)

3-g footbath

EXPERIMENTAL

Footbath with 3g ginger flour per liter of water

Other: 3-g footbath

6-g footbath

EXPERIMENTAL

Footbath with 6g ginger flour per liter of water

Other: 6-g footbath

12-g footbath

EXPERIMENTAL

Footbath with 12g ginger flour per liter of water

Other: 12-g footbath

Warm water footbath

PLACEBO COMPARATOR

Footbath with warm water only

Other: Warm water footbath

Interventions

A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 36 g ginger flour (3 g per l), followed by a ten-minute post-intervention rest period.

3-g footbath

A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 72 g ginger flour (6 g per l), followed by a ten-minute post-intervention rest period.

6-g footbath

A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 144 g ginger flour (12 g per l), followed by a ten-minute post-intervention rest period.

12-g footbath

A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C), followed by a ten-minute post-intervention rest period.

Warm water footbath

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Written informed consent
  • Age between 18 and 55 years

You may not qualify if:

  • Chronic skin lesions at the lower legs or feet
  • Known intolerance or hypersensitivity to ginger preparations
  • Cardiac arrhythmia
  • Cardiac pacemaker
  • Asthma bronchiale
  • Consumption of HRV-modulating medication (especially tricyclic antidepressants, beta blockers)
  • Pregnancy
  • Insufficient knowledge of the german language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arcim Institute

Filderstadt, Baden-Wurttemberg, 70794, Germany

Location

Study Officials

  • Jan Vagedes, Dr.

    Arcim Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2019

First Posted

August 9, 2019

Study Start

September 16, 2019

Primary Completion

January 30, 2020

Study Completion

January 31, 2020

Last Updated

April 28, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
The data will be made available upon publication for a duration of three months.
Access Criteria
The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.

Locations